Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

ClinicalTrials.gov ID: NCT00195676

Public ClinicalTrials.gov record NCT00195676. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Open-Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects Who Completed a Preceding Psoriasis Clinical Study With Adalimumab

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The two objectives of this study were to evaluate long-term efficacy and safety of adalimumab treatment in participants who had moderate to severe chronic plaque psoriasis and to evaluate the effectiveness of adalimumab retreatment in participants who had therapeutic response to adalimumab and were then withdrawn from adalimumab treatment.

Study identification

NCT ID
NCT00195676
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
1,469 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2004 (Type not available)
Primary completion
Oct 2009 (Actual)
Completion
Oct 2009 (Actual)
Last update posted
Apr 13, 2011

2004 – 2009

United States locations

U.S. sites
66
U.S. states
30
U.S. cities
60
Facility City State ZIP Site status
Site Reference ID/Investigator# 1263 Birmingham Alabama 35205 —
Site Reference ID/Investigator# 1259 Buckner 13075 PI Alabama 35233 —
Site Reference ID/Investigator# 2427 Scottsdale Arizona 85251 —
Site Reference ID/Investigator# 2433 Tucson Arizona 85710 —
Site Reference ID/Investigator# 100 Little Rock Arkansas 72205 —
Site Reference ID/Investigator# 1798 Bakersfield California 93309 —
Site Reference ID/Investigator# 122 Fresno California 93720 —
Site Reference ID/Investigator# 1669 Irvine California 92697 —
Site Reference ID/Investigator# 1285 Oceanside California 92056 —
Site Reference ID/Investigator# 86 San Diego California 92123 —
Site Reference ID/Investigator# 1679 Santa Monica California 90404 —
Site Reference ID/Investigator# 1677 Torrance California 90503 —
Site Reference ID/Investigator# 1269 Longmont Colorado 80501 —
Site Reference ID/Investigator# 1275 New Haven Connecticut 06511 —
Site Reference ID/Investigator# 96 Jacksonville Florida 32204 —
Site Reference ID/Investigator# 2431 Pinellas Park Florida 33781 —
Site Reference ID/Investigator# 1273 South Miami Florida 33143 —
Site Reference ID/Investigator# 2432 West Palm Beach Florida 33407 —
Site Reference ID/Investigator# 98 Alpharetta Georgia 30022 —
Site Reference ID/Investigator# 1674 Newnan Georgia 30263 —
Site Reference ID/Investigator# 1670 Snellville Georgia 30078 —
Site Reference ID/Investigator# 1264 Chicago Illinois 60612 —
Site Reference ID/Investigator# 1801 Maywood Illinois 60153 —
Site Reference ID/Investigator# 1681 Springfield Illinois 62702 —
Site Reference ID/Investigator# 1267 Indianapolis Indiana 46256 —
Site Reference ID/Investigator# 1671 Indianapolis Indiana 46260 —
Site Reference ID/Investigator# 1258 Louisville Kentucky 40202 —
Site Reference ID/Investigator# 1281 Shreveport Louisiana 71103 —
Site Reference ID/Investigator# 1668 Andover Massachusetts 01810 —
Site Reference ID/Investigator# 1683 Boston Massachusetts 02114 —
Site Reference ID/Investigator# 83 Worcester Massachusetts 01610 —
Site Reference ID/Investigator# 93 Ann Arbor Michigan 48109 —
Site Reference ID/Investigator# 92 Fridley Minnesota 55432 —
Site Reference ID/Investigator# 1262 Minneapolis Minnesota 55455 —
Site Reference ID/Investigator# 1657 St Louis Missouri 63110 —
Site Reference ID/Investigator# 89 St Louis Missouri 63117 —
Site Reference ID/Investigator# 1673 Omaha Nebraska 68131 —
Site Reference ID/Investigator# 2119 New Brunswick New Jersey 08903 —
Site Reference ID/Investigator# 1672 New York New York 10016 —
Site Reference ID/Investigator# 1797 New York New York 10025 —
Site Reference ID/Investigator# 95 New York New York 10029 —
Site Reference ID/Investigator# 1655 New York New York 10032 —
Site Reference ID/Investigator# 88 Rochester New York 14623 —
Site Reference ID/Investigator# 1256 Williamsville New York 14221 —
Site Reference ID/Investigator# 1266 Raleigh North Carolina 27612 —
Site Reference ID/Investigator# 1265 Cincinnati Ohio 45219 —
Site Reference ID/Investigator# 90 Cleveland Ohio 44106 —
Site Reference ID/Investigator# 2434 Columbus Ohio 43212 —
Site Reference ID/Investigator# 1260 Lake Oswego Oregon 97035 —
Site Reference ID/Investigator# 1667 Portland Oregon 97210 —
Site Reference ID/Investigator# 121 Portland Oregon 97223 —
Site Reference ID/Investigator# 1323 Hershey Pennsylvania 17033 —
Site Reference ID/Investigator# 1277 Philadelphia Pennsylvania 19103 —
Site Reference ID/Investigator# 99 Johnston Rhode Island 02919 —
Site Reference ID/Investigator# 1676 Providence Rhode Island 02903 —
Site Reference ID/Investigator# 97 Greer South Carolina 29651 —
Site Reference ID/Investigator# 5199 Mt. Pleasant South Carolina 29464 —
Site Reference ID/Investigator# 1800 Goodlettsville Tennessee 37072 —
Site Reference ID/Investigator# 1282 Nashville Tennessee 37215 —
Site Reference ID/Investigator# 87 Dallas Texas 75246-1613 —
Site Reference ID/Investigator# 1279 Houston Texas 77030 —
Site Reference ID/Investigator# 1665 San Antonio Texas 78229 —
Site Reference ID/Investigator# 1268 Tyler Texas 75703 —
Site Reference ID/Investigator# 2079 Salt Lake City Utah 84132 —
Site Reference ID/Investigator# 123 Norfolk Virginia 23507 —
Site Reference ID/Investigator# 1653 Seattle Washington 98101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00195676, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2011 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00195676 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →